Open AccessP1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG‐0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA
Author(s) -
Stegelmann F.,
Jahn E.,
Koschmieder S.,
Heidel F.,
Hochhaus A.,
Hebart H.,
Isfort S.,
Reiter A.,
Bangerter M.,
Waller C. F.,
Wolleschak D.,
Scheid C.,
Göthert J.,
Schafhausen P.,
Kindler T.,
Radsak M. P.,
Gattermann N.,
Möhle R.,
Bubnoff N.,
Schrade A.,
Brümmendorf T.,
Döhner H.,
Griesshammer M.,
Döhner K.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847088.09306.08
Subject(s) - pomalidomide , myelofibrosis , medicine , ruxolitinib , cytopenia , anemia , gastroenterology , international prognostic scoring system , clinical endpoint , phases of clinical research , lenalidomide , clinical trial , bone marrow , multiple myeloma , myelodysplastic syndromes